216 related articles for article (PubMed ID: 19662737)
1. Endocrine and metabolic disorders associated with human immune deficiency virus infection.
Unachukwu CN; Uchenna DI; Young EE
West Afr J Med; 2009 Jan; 28(1):3-9. PubMed ID: 19662737
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and metabolic abnormalities among HIV-infected patients: a current review.
Kibirige D; Ssekitoleko R
Int J STD AIDS; 2013 Aug; 24(8):603-11. PubMed ID: 23970578
[TBL] [Abstract][Full Text] [Related]
3. Endocrinopathies in children infected with human immunodeficiency virus.
Loomba-Albrecht LA; Bregman T; Chantry CJ
Endocrinol Metab Clin North Am; 2014 Sep; 43(3):807-28. PubMed ID: 25169569
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.
Anuurad E; Semrad A; Berglund L
Metab Syndr Relat Disord; 2009 Oct; 7(5):401-10. PubMed ID: 19355810
[TBL] [Abstract][Full Text] [Related]
5. Endocrine manifestations of human immunodeficiency virus (HIV) infection.
Marks JB
Am J Med Sci; 1991 Aug; 302(2):110-7. PubMed ID: 1897556
[TBL] [Abstract][Full Text] [Related]
6. Endocrinological aspects of HIV infection.
Mirza FS; Luthra P; Chirch L
J Endocrinol Invest; 2018 Aug; 41(8):881-899. PubMed ID: 29313284
[TBL] [Abstract][Full Text] [Related]
7. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
Cotter AG; Powderly WG
Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):501-15. PubMed ID: 21663843
[TBL] [Abstract][Full Text] [Related]
8. [Endocrine abnormalities in HIV-infected patients].
Krysiak R; Kedzia A; Krupej-Kedzierska J; Okopień B
Przegl Lek; 2013; 70(2):76-80. PubMed ID: 23879008
[TBL] [Abstract][Full Text] [Related]
9. Management of the metabolic effects of HIV and HIV drugs.
Brown TT; Glesby MJ
Nat Rev Endocrinol; 2011 Sep; 8(1):11-21. PubMed ID: 21931374
[TBL] [Abstract][Full Text] [Related]
10. HIV infection, antiretroviral therapy and cardiovascular risk.
Barbaro G
J Cardiovasc Risk; 2002 Oct; 9(5):295-300. PubMed ID: 12394324
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic disturbances associated with HAART].
Olczak A
Przegl Epidemiol; 2007; 61(4):639-46. PubMed ID: 18572495
[TBL] [Abstract][Full Text] [Related]
12. Endocrinology and Metabolism Clinics of North America. HIV and endocrine disorders. Foreword.
LeRoith D
Endocrinol Metab Clin North Am; 2014 Sep; 43(3):xiii-xv. PubMed ID: 25169570
[No Abstract] [Full Text] [Related]
13. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use.
Khalsa JH; Genser S; Coates P; Francis H
Clin Infect Dis; 2003; 37 Suppl 2():S37-42. PubMed ID: 12942372
[TBL] [Abstract][Full Text] [Related]
14. How best to approach endocrine evaluation in patients with HIV in the era of combined antiretroviral therapy?
Wren A
Clin Endocrinol (Oxf); 2013 Sep; 79(3):310-3. PubMed ID: 23790012
[TBL] [Abstract][Full Text] [Related]
15. Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease.
Cooper OB; Brown TT; Dobs AS
Clin Infect Dis; 2003; 37 Suppl 2():S132-6. PubMed ID: 12942387
[TBL] [Abstract][Full Text] [Related]
16. Human Immunodeficiency Virus Infection and the Endocrine System.
Zaid D; Greenman Y
Endocrinol Metab (Seoul); 2019 Jun; 34(2):95-105. PubMed ID: 31257738
[TBL] [Abstract][Full Text] [Related]
17. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
Barbaro G; Klatt EC
Curr Pharm Des; 2003; 9(18):1475-81. PubMed ID: 12769727
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome.
Sellmeyer DE; Grunfeld C
Endocr Rev; 1996 Oct; 17(5):518-32. PubMed ID: 8897023
[TBL] [Abstract][Full Text] [Related]
19. Endocrine complications associated with human immunodeficiency virus infection.
Etzel JV; Brocavich JM; Torre M
Clin Pharm; 1992 Aug; 11(8):705-13. PubMed ID: 1511543
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
Barbaro G
Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
